|
BLMH expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.00330000050309E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.00934882253068E-12 |
| Normal-vs-Stage2 |
1.063150E-01 |
| Normal-vs-Stage3 |
1.197230E-01 |
| Normal-vs-Stage4 |
2.726100E-02 |
| Stage1-vs-Stage2 |
1.420470E-02 |
| Stage1-vs-Stage3 |
2.89120000052101E-07 |
| Stage1-vs-Stage4 |
2.682800E-03 |
| Stage2-vs-Stage3 |
5.002400E-01 |
| Stage2-vs-Stage4 |
9.896400E-01 |
| Stage3-vs-Stage4 |
3.611000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.19959999991914E-07 |
| Normal-vs-AfricanAmerican |
9.642200E-03 |
| Normal-vs-Asian |
3.91399999999376E-06 |
| Caucasian-vs-AfricanAmerican |
8.159600E-01 |
| Caucasian-vs-Asian |
9.973700E-02 |
| AfricanAmerican-vs-Asian |
8.722100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.640200E-04 |
| Normal-vs-Female |
1.62450053409202E-10 |
| Male-vs-Female |
2.27499999999603E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.286400E-01 |
| Normal-vs-Age(41-60Yrs) |
8.44170000013911E-07 |
| Normal-vs-Age(61-80Yrs) |
2.03269999998756E-06 |
| Normal-vs-Age(81-100Yrs) |
1.090430E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.505200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.948200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.774600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.949400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.885600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.400400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.754700E-04 |
| Normal-vs-Grade 2 |
7.27909954534312E-11 |
| Normal-vs-Grade 3 |
5.029500E-04 |
| Normal-vs-Grade 4 |
5.017000E-01 |
| Grade 1-vs-Grade 2 |
9.024400E-02 |
| Grade 1-vs-Grade 3 |
6.569400E-04 |
| Grade 1-vs-Grade 4 |
1.83012999999121E-05 |
| Grade 2-vs-Grade 3 |
4.590000E-04 |
| Grade 2-vs-Grade 4 |
1.03699999998152E-06 |
| Grade 3-vs-Grade 4 |
3.916400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
7.674600E-01 |
| ccA subtype-vs-ccB subtype |
2.40918396343659E-14 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.67699999995297E-06 |
| Normal-vs-N1 |
3.926200E-01 |
| N0-vs-N1 |
4.424000E-01 |
|
|
